Improving Definitive Therapy Among Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections: Predictors of Early Therapeutic Switch to Linezolid or Daptomycin
نویسندگان
چکیده
800. Improving Definitive Therapy Among Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections: Predictors of Early Therapeutic Switch to Linezolid or Daptomycin Marin Schweizer, PhD; Kelly Richardson, PhD; Mary Vaughan Sarrazin, PhD; Michael Jones, PhD; Daniel Livorsi, MD, MSc; Rajeshwari Nair, MBBS, PhD; Michihiko Goto, MD, MSCI; Bruce Alexander, PharmD; Brice Beck, MA and Eli Perencevich, MD, MS, FIDSA, FSHEA; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, Iowa City VA Health Care System, Iowa City, Iowa, Iowa City VA Medical Center, Iowa City, Iowa, University of Iowa, Iowa City, Iowa, Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa
منابع مشابه
Evaluation of telavancin dose capping in a large community hospital
800. Improving Definitive Therapy Among Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections: Predictors of Early Therapeutic Switch to Linezolid or Daptomycin Marin Schweizer, PhD; Kelly Richardson, PhD; Mary Vaughan Sarrazin, PhD; Michael Jones, PhD; Daniel Livorsi, MD, MSc; Rajeshwari Nair, MBBS, PhD; Michihiko Goto, MD, MSCI; Bruce Alexander, PharmD; Brice Beck, ...
متن کاملThe Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy
800. Improving Definitive Therapy Among Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections: Predictors of Early Therapeutic Switch to Linezolid or Daptomycin Marin Schweizer, PhD; Kelly Richardson, PhD; Mary Vaughan Sarrazin, PhD; Michael Jones, PhD; Daniel Livorsi, MD, MSc; Rajeshwari Nair, MBBS, PhD; Michihiko Goto, MD, MSCI; Bruce Alexander, PharmD; Brice Beck, ...
متن کاملImpact of minocycline, polymyxin B, meropenem, and amikacin on growth-prevention of Acinetobacter baumannii with various biofilm-forming capabilities
800. Improving Definitive Therapy Among Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections: Predictors of Early Therapeutic Switch to Linezolid or Daptomycin Marin Schweizer, PhD; Kelly Richardson, PhD; Mary Vaughan Sarrazin, PhD; Michael Jones, PhD; Daniel Livorsi, MD, MSc; Rajeshwari Nair, MBBS, PhD; Michihiko Goto, MD, MSCI; Bruce Alexander, PharmD; Brice Beck, ...
متن کاملRetrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid
Objective. The objective of this analysis was to compare clinical and cost outcomes associated with patients who had suspected or documented methicillin-resistant Staphylococcus aureus (MRSA) infections treated with daptomycin, vancomycin, or linezolid in complicated skin and skin structure infections (cSSSIs). Design. This was a retrospective analysis conducted from February to June of 2007. A...
متن کاملEconomic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
BACKGROUND Previous economic analyses evaluating treatment of methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft-tissue infections (cSSTI) failed to include all direct treatment costs such as outpatient parenteral antibiotic therapy (OPAT). Our objective was to develop an economic model from a US payer perspective that includes all direct inpatient and outpatient costs...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 4 شماره
صفحات -
تاریخ انتشار 2017